New research shows patients admitted to National Health Service (NHS) hospitals in the United Kingdom for atrial fibrillation or heart failure over the weekend face a higher risk of dying over the next five years than those admitted during normal hours. The research, led by Rahul Potluri, M.D., founder of the ACALM study unit at Aston University, was presented at the British Cardiovascular Society (BCS) Conference, June 6-8 in Manchester.

IBM announced it has formed a Watson Health medical imaging collaborative, a global initiative comprised of more than fifteen leading health systems, academic medical centers, ambulatory radiology providers and imaging technology companies. The collaborative aims to bring cognitive imaging into daily practice to help doctors address breast, lung and other cancers; diabetes; eye health; brain disease; and heart disease and related conditions, such as stroke.

June 27, 2016 — A new study in the Journal of Medical Imaging and Radiation Sciences surveyed doctors, radiologists and ...

Measuring antibody levels in the blood could be used to detect a person’s heart attack risk after researchers, part-funded by the British Heart Foundation (BHF), discovered that higher levels of these antibodies are linked to a lower heart attack risk.

Biotronik announced it was the winner of the Cardiostim Innovation Award in the category “Best Practice Improvement” for its MRI AutoDetect feature. The award was given at the Cardiostim 2016 conference, June 8-11 in Nice, France.

Zoll Medical Corp. announced that patients experience a high one-year survival rate following use of the LifeVest Wearable Defibrillator. New results from the Prospective Registry of Patients Using the Wearable Defibrillator (WEARIT-II Registry) were presented by Valentina Kutyifa, M.D., Ph.D., University of Rochester Medical Center, during the Late-Breaking Clinical Trials session at CardioStim/EuroPace 2016.